MorphoSys's proprietary HuCAL antibody library is one of the most powerful methods available for generating fully human antibodies. By successfully applying this and other proprietary technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare. Via its business unit AbD Serotec, MorphoSys is expanding the reach of its technologies in the diagnostics and research markets.